Jayakar V Nayak, MD
Otolaryngology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 16
- 2 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
16 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Nayak’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
16 of 16 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A109144 · Current
Licensed to practise in California · since 2009 · expires 2027-05-31 · University of Pennsylvania School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$42,469
Medicare paid this office $42,469 for 82 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Biopsy or removal of nasal polyp or tissue using an endoscope | 19 | $5,807 | $200 |
| Long return visit (40+ min) | 26 | $3,644 | $126 |
| Diagnostic exam of nasal passages using an endoscope | 57 | $3,535 | $54 |
| Return visit (30+ min) | 21 | $2,019 | $84 |
| Short return visit (20+ min) | 11 | $714 | $60 |
Who their Medicare patients are
82 Original Medicare patients in 2024. Average age 69 · Women 39% · Also on Medicaid 20% · Health risk score 1.43. Above the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 62% · Diabetes 32% · Chronic kidney disease 27% · Depression 26% · Coronary heart disease 21% · COPD 13% · Atrial fibrillation 13%.
The office billed $437,406, Medicare allowed $53,939 and paid $42,469; for 275 services of 42 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 82 | 275 | 69 | 1.43 | $437,406 | $42,469 |
| 2023 | 75 | 280 | 68 | 1.20 | $500,897 | $46,355 |
| 2022 | 75 | 287 | 69 | 1.42 | $467,903 | $46,424 |
| 2021 | 58 | 254 | 68 | 1.12 | $422,157 | $35,767 |
| 2020 | 70 | 348 | 67 | 1.39 | $706,025 | $64,391 |
| 2019 | 98 | 408 | 68 | 1.38 | $579,656 | $52,706 |
| 2018 | 73 | 350 | 70 | 1.21 | $525,827 | $46,970 |
| 2017 | 61 | 280 | 67 | 1.47 | $632,663 | $48,057 |
| 2016 | 73 | 359 | 66 | 1.67 | $930,479 | $64,376 |
| 2015 | 88 | 419 | 70 | 1.36 | $682,779 | $59,653 |
| 2014 | 95 | 393 | 70 | 1.74 | $669,133 | $61,249 |
| 2013 | 105 | 368 | 69 | 1.70 | $513,476 | $54,802 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Biopsy or removal of nasal polyp or tissue using an endoscope | 28 | $9,099 | $212 |
| Long return visit (40+ min) | 17 | $2,650 | $132 |
| New patient visit (60+ min) | 14 | $2,032 | $145 |
| Diagnostic exam of nasal passages using an endoscope | 49 | $2,030 | $34 |
| Return visit (30+ min) | 16 | $1,763 | $88 |
| Short return visit (20+ min) | 12 | $671 | $52 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $497 | $41 |
2022: 6 services
| Biopsy or removal of nasal polyp or tissue using an endoscope | 23 | $7,744 | $209 |
| Long return visit (40+ min) | 22 | $3,380 | $121 |
| Return visit (30+ min) | 23 | $2,159 | $86 |
| Diagnostic exam of nasal passages using an endoscope | 53 | $1,625 | $24 |
| New patient visit (60+ min) | 12 | $1,559 | $130 |
| Short return visit (20+ min) | 14 | $840 | $53 |
2021: 5 services
| Biopsy or removal of nasal polyp or tissue using an endoscope | 16 | $5,478 | $203 |
| Long return visit (40+ min) | 16 | $1,969 | $116 |
| Return visit (30+ min) | 18 | $1,811 | $91 |
| Diagnostic exam of nasal passages using an endoscope | 43 | $1,358 | $22 |
| Short return visit (20+ min) | 14 | $1,066 | $56 |
2020: 6 services
| Biopsy or removal of nasal polyp or tissue using an endoscope | 30 | $9,584 | $204 |
| Computer-assisted procedure outside membrane covering brain | 15 | $2,404 | $160 |
| Removal of nasal sinus tissue using an endoscope | 12 | $2,141 | $178 |
| Diagnostic exam of nasal passages using an endoscope | 44 | $1,474 | $20 |
| Return visit (30+ min) | 16 | $1,313 | $66 |
| Short return visit (20+ min) | 19 | $1,098 | $46 |
2019: 7 services
| Biopsy or removal of nasal polyp or tissue using an endoscope | 32 | $9,836 | $189 |
| Diagnostic exam of nasal passages using an endoscope | 66 | $3,801 | $40 |
| Return visit (30+ min) | 24 | $2,010 | $69 |
| Short return visit (20+ min) | 32 | $1,811 | $45 |
| New patient visit (45+ min) | 16 | $1,778 | $111 |
| Long return visit (40+ min) | 16 | $1,529 | $90 |
| Short return visit | 14 | $370 | $23 |
2018: 6 services
| Biopsy or removal of nasal polyp or tissue using an endoscope | 25 | $7,864 | $197 |
| Diagnostic exam of nasal passages using an endoscope | 47 | $3,852 | $51 |
| Short return visit (20+ min) | 29 | $1,774 | $42 |
| Computer-assisted procedure outside membrane covering brain | 11 | $1,691 | $154 |
| Return visit (30+ min) | 22 | $1,680 | $65 |
| Short return visit | 12 | $319 | $21 |
2017: 6 services
| Biopsy or removal of nasal polyp or tissue using an endoscope | 19 | $4,826 | $201 |
| Diagnostic exam of nasal passages using an endoscope | 46 | $3,715 | $55 |
| Removal of nasal sinus using an endoscope | 11 | $3,570 | $297 |
| Computer-assisted procedure outside membrane covering brain | 13 | $2,183 | $156 |
| Short return visit (20+ min) | 31 | $1,917 | $44 |
| Long return visit (40+ min) | 11 | $1,295 | $100 |
2016: 8 services
| Exploration of nasal sinus using an endoscope | 13 | $8,278 | $552 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 18 | $5,832 | $201 |
| Diagnostic exam of nasal passages using an endoscope | 50 | $4,556 | $56 |
| Removal of nasal sinus using an endoscope | 12 | $3,601 | $257 |
| Short return visit (20+ min) | 34 | $2,233 | $44 |
| Incision of sphenoid nasal sinus using an endoscope | 11 | $1,787 | $149 |
| Return visit (30+ min) | 19 | $1,471 | $64 |
| Incision of nasal sinus using an endoscope | 11 | $1,258 | $114 |
2015: 7 services
| Diagnostic exam of nasal passages using an endoscope | 79 | $7,139 | $57 |
| Reshaping of nasal cartilage | 12 | $5,357 | $446 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 17 | $5,079 | $181 |
| Short return visit (20+ min) | 47 | $2,504 | $42 |
| Removal of nasal sinus tissue using an endoscope | 12 | $2,220 | $159 |
| Return visit (30+ min) | 23 | $1,768 | $68 |
| Short return visit | 16 | $386 | $23 |
2014: 9 services
| Exploration of nasal sinus using an endoscope | 14 | $9,009 | $643 |
| Diagnostic exam of nasal passages using an endoscope | 74 | $5,929 | $57 |
| Removal of nasal air passage under lining tissue | 11 | $4,579 | $416 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 18 | $4,035 | $168 |
| Removal of nasal sinus using an endoscope | 13 | $3,351 | $258 |
| Short return visit (20+ min) | 46 | $2,988 | $44 |
| Computer-assisted procedure outside membrane covering brain | 11 | $1,801 | $164 |
| New patient visit (30+ min) | 20 | $1,215 | $61 |
| Short return visit | 17 | $490 | $21 |
2013: 5 services
| Diagnostic exam of nasal passages using an endoscope | 64 | $4,921 | $55 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 12 | $3,196 | $200 |
| Short return visit (20+ min) | 50 | $2,516 | $43 |
| New patient visit (30+ min) | 29 | $1,856 | $64 |
| Short return visit | 21 | $539 | $22 |
Money from drug and device companies
$43,181 in 2025
| 2025 | 6 | 33 | $40,925 | $43,181 |
| 2024 | 6 | 15 | $7,133 | $7,693 |
| 2023 | 3 | 9 | $1,250 | $1,781 |
| 2022 | 4 | 6 | None | $367 |
| 2021 | 2 | 2 | None | $55 |
| 2020 | 2 | 12 | None | $9,280 |
| 2019 | 6 | 22 | $13,036 | $14,062 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
Spirair, Inc.
$1,811
Held by this doctor · 2025, 2024 · Stock Ownership, Common Stock Ownership
Published ownership or investment in a drug or device company. This is not proof that care is biased.
A payment is not proof that care is biased.
| Spirair | Septalign | $22,650 | 2 payments
|
| Aerin Medical | Vivaer Stylus | $15,276 | 13 payments
|
| Genzyme | Dupixent | $4,667 | 1 payment
|
| Integra LifeSciences | Acclarent Aera | $426 | 4 payments
|
| Stryker | Scopis Ent | $145 | 2 payments
|
| KARL STORZ Endoscopy-America | Solo+ Ttd Handpiece | $18 | 1 payment
|
See all 23 published payments
| Stryker | Meals · 2025-12-05 | Scopis Ent | $124 |
| Aerin Medical | Meals · 2025-11-06 | Vivaer Stylus | $178 |
| Aerin Medical | Travel · 2025-11-06 | Vivaer Stylus | $939 |
| Aerin Medical | Consulting · 2025-11-06 | Vivaer Stylus | $3,438 |
| Aerin Medical | Consulting · 2025-11-06 | Vivaer Stylus | $2,500 |
| Aerin Medical | Consulting · 2025-10-31 | Vivaer Stylus | $5,000 |
| Aerin Medical | Meals · 2025-09-30 | Vivaer Stylus | $52 |
| Aerin Medical | Consulting · 2025-09-22 | Vivaer Stylus | $1,250 |
| Genzyme | Paid to speak or teach · 2025-09-04 | Dupixent | $4,667 |
| Integra LifeSciences | Meals · 2025-08-01 | Acclarent Aera | $83 |
| Aerin Medical | Meals · 2025-07-14 | Vivaer Stylus | $24 |
| Integra LifeSciences | Meals · 2025-07-11 | Acclarent Aera | $148 |
| Aerin Medical | Meals · 2025-07-08 | Vivaer Stylus | $40 |
| Integra LifeSciences | Meals · 2025-05-20 | Acclarent Aera | $175 |
| KARL STORZ Endoscopy-America | Meals · 2025-05-14 | Solo+ Ttd Handpiece | $18 |
| Aerin Medical | Meals · 2025-05-09 | Vivaer Stylus | $60 |
| Aerin Medical | Consulting · 2025-05-07 | Vivaer Stylus | $500 |
| Aerin Medical | Consulting · 2025-04-30 | Vivaer Stylus | $1,250 |
| Aerin Medical | Meals · 2025-04-29 | Vivaer Stylus | $44 |
| Integra LifeSciences | Meals · 2025-03-17 | Acclarent Aera | $20 |
| Spirair | Consulting · 2025-02-18 | Septalign | $22,321 |
| Spirair | Travel · 2025-02-18 | Septalign | $329 |
| Stryker | Meals · 2025-01-29 | Hemopore | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $7,693
| Aerin Medical | Vivaer Stylus | $5,520 | 6 payments
|
| Spirair | Septalign | $1,633 | 1 payment
|
| Integra LifeSciences | Acclarent Aera | $367 | 5 payments
|
| Stryker | Core | $73 | 1 payment
|
| Medtronic | Straightshot | $72 | 1 payment
|
| Acclarent | Trudi Nav Cable | $27 | 1 payment
|
2023: $1,781
| Aerin Medical | Vivaer Stylus | $1,422 | 4 payments
|
| Stryker | Core | $303 | 4 payments
|
| Acclarent | Trudi Nav Cable | $56 | 1 payment
|
2022: $367
| Stryker | Xpress Ent Dilation System | $153 | 1 payment
|
| Aerin Medical | None | $141 | 2 payments
|
| Acclarent | Acclarent Navwire | $43 | 2 payments
|
| Medtronic | Mazor X System | $30 | 1 payment
|
2021: $55
| Stryker | N/A | $31 | 1 payment
|
| Medtronic | Stealthstation | $24 | 1 payment
|
2020: $9,280
| Olympus Corporation of the Americas | Olympus Ent Instruments | $9,259 | 11 payments
|
| Medtronic USA | Fusion | $21 | 1 payment
|
2019: $14,062
| Cook | Cook Medical Rhinology | $7,700 | 2 payments
|
| Genzyme | Dupixent | $2,200 | 3 payments
|
| Olympus America | Pk Diego | $1,785 | 2 payments
|
| Baxter Healthcare | Floseal | $1,622 | 2 payments
|
| Olympus Corporation of the Americas | Pk Diego | $662 | 12 payments
|
| Cook Medical | Cook Medical Sinus Access | $93 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1841451556
- Licence
- CA A109144, PA MD434096California A109144: Current · expires 2027-05-31
- Trained
- University of Pittsburgh School of Medicine, 2003
- Group
- Stanford Health Care
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Otolaryngology (207Y00000X); Surgery (208600000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2008-06-24
- NPI last updated
- 2024-04-29
- NPI record certified
- 2024-04-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3400 Spruce St, Philadelphia, PA, 19104